Cargando…

Systemic IL-6 and Severe Asthma

Detalles Bibliográficos
Autores principales:	Lipworth, Brian, Chan, Rory, Kuo, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605205/ https://www.ncbi.nlm.nih.gov/pubmed/32687393 http://dx.doi.org/10.1164/rccm.202006-2354LE

Ejemplares similares

Sex Hormones and Asthma: Don’t Forget Progesterone
por: Lipworth, Brian, et al.
Publicado: (2020)

Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma
por: Lipworth, Brian, et al.
Publicado: (2023)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Resistance Heterogeneity and Small Airway Asthma Phenotype
por: Lipworth, Brian, et al.
Publicado: (2019)

COVID-19: Start with the nose
por: Lipworth, Brian, et al.
Publicado: (2020)

Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumab
por: Chan, Rory, et al.
Publicado: (2023)

Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
por: Chan, Rory, et al.
Publicado: (2023)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on
por: Lipworth, Brian, et al.
Publicado: (2020)

Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword
por: Lipworth, Brian, et al.
Publicado: (2021)

Predicting Severe Outcomes in COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study
por: Chan, Rory, et al.
Publicado: (2022)

Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection
por: Lipworth, Brian, et al.
Publicado: (2020)

Impact of Biologic Therapy on the Small Airways Asthma Phenotype
por: Chan, Rory, et al.
Publicado: (2022)

Role of IL-6 in Severe Inflammation
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
por: Chan, Rory, et al.
Publicado: (2022)

Is IL-6 the Right Target in COVID-19 Severe Pneumonia?
por: Blot, Mathieu, et al.
Publicado: (2021)

Does unified allergic airway disease impact on lung function and type 2 biomarkers?
por: Kuo, Chris RuiWen, et al.
Publicado: (2019)

Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

COVID-19: Clean up on IL-6
por: Hedrick, Tanner L., et al.
Publicado: (2020)

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19
por: Garbers, Christoph, et al.
Publicado: (2021)

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply
por: Bovijn, Jonas, et al.
Publicado: (2021)

Normal spirometry equates to normal impulse oscillometry in healthy subjects
por: Lipworth, Brian, et al.
Publicado: (2021)

Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics
por: Kagohashi, Katsunori, et al.
Publicado: (2022)

Is bronchial thermoplasty safe in allergic bronchopulmonary aspergillosis or severe asthma with fungal sensitization?
por: Muthu, Valliappan, et al.
Publicado: (2021)

Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
por: Deng, Zhenan, et al.
Publicado: (2023)

High mobility group box 1 levels as potential predictors of asthma severity
por: Xu, Shuanglan, et al.
Publicado: (2023)

Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients
por: Yang, Penghui, et al.
Publicado: (2021)

Remote visits for severe asthma patients after the COVID-19 pandemic: how to address the challenge?
por: Sánchez-García, S., et al.
Publicado: (2023)

Cocaine in Asthma
por: D'Sylva, C. R.
Publicado: (1891)

Asthma and Pneumonia
por: Singh, Har Narain
Publicado: (1947)

Reflex Asthma
por: Abdulla, M.
Publicado: (1931)

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
por: Couillard, Simon, et al.
Publicado: (2021)

Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19
por: Bovijn, Jonas, et al.
Publicado: (2020)

(Oral) enoximone in asthma
por: Beute, Jan
Publicado: (2020)

Kerosine Oil in Asthma
por: Biswas, D. L.
Publicado: (1922)

Cotton Seed Asthma
por: Khan, Matloob
Publicado: (1926)

Cannot write session to /tmp/vufind_sessions/sess_ik06asqgca7q5qarnq6sc5v22r